Clinical trial
Phase 1/2 Study of Bosutinib in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT04744532 is registered in ClinicalTrials.gov with Kyoto University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1/2 Study of Bosutinib in Patients With Amyotrophic Lateral Sclerosis (ALS)
- Lead sponsor
- Kyoto University
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 19, 2019
- Completion date
- July 31, 2024
- Enrollment
- 46 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.